pravastatin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases total cholesterol (TC)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“Total cholesterol and LDLC were significantly reduced with 10 mg daily of pravastatin by 12% and 19%, respectively, at the 1-year follow-up and continuously thereafter.”
Quoted verbatim from Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke).. - Study
- RCT
- Dose
- 10 mg daily
- Population
- Japanese patients aged 45-80 with noncardioembolic ischemic stroke and serum total cholesterol 180-240 mg/dL without statins, pravastatin 10 mg daily versus no statin (open-label); J-STARS Echo substudy
Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke).2018PMID:29191850Permalink
Keep reading
- Everything the graph holds on pravastatin
- Every compound studied against Total cholesterol (TC)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45EG77SYNMWY8PDXC03XFTC